How does the nanopore platform affect the cost of the test?

The MinION device has a relatively low initial capital cost compared to large hospital-grade sequencing instruments (an NGS machine can cost $500,000+; a MinION costs a few thousand dollars). The consumable flow cells and reagents represent the primary variable cost per run. The osmium reagent chemistry, while proprietary, is scalable. These economics make the Yenos platform accessible to a specialized commercial laboratory without requiring the massive capital investment of traditional large-lab infrastructure. The $995 OncuraKit price reflects the cost of the at-home kit, overnight shipping (both ways), laboratory analysis, quality control, confirmatory testing if needed, report generation, and physician consultation support — not just the nanopore run itself.